Clal Biotechnology Industries Ltd (CBI) — Cash Flow-to-Debt Ratio
Clal Biotechnology Industries Ltd (CBI) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2025, meaning its operating cash flow of ILA-1.06 Million could theoretically repay 0% of its total liabilities (ILA19.52 Million) in one year. See financial agility of Clal Biotechnology Industries Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clal Biotechnology Industries Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Clal Biotechnology Industries Ltd across 19 annual periods. For the full cash flow conversion analysis, see Clal Biotechnology Industries Ltd (CBI) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Clal Biotechnology Industries Ltd (2006–2024)
Year-by-year debt coverage analysis for Clal Biotechnology Industries Ltd. Check Clal Biotechnology Industries Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.30x | ILA-6.48 Million | ILA21.52 Million | ▼ -30.7% |
| 2023 | -0.23x | ILA-8.51 Million | ILA36.98 Million | ▲ +85.3% |
| 2022 | -1.56x | ILA-59.04 Million | ILA37.79 Million | ▼ -302.7% |
| 2021 | -0.39x | ILA-41.33 Million | ILA106.55 Million | ▼ -17.0% |
| 2020 | -0.33x | ILA-33.23 Million | ILA100.24 Million | ▼ -246.1% |
| 2019 | 0.23x | ILA27.03 Million | ILA119.12 Million | ▲ +138.7% |
| 2018 | -0.59x | ILA-86.98 Million | ILA148.46 Million | ▼ -45.0% |
| 2017 | -0.40x | ILA-91.41 Million | ILA226.14 Million | ▼ -31.4% |
| 2016 | -0.31x | ILA-112.63 Million | ILA366.21 Million | ▲ +7.9% |
| 2015 | -0.33x | ILA-147.00 Million | ILA440.31 Million | ▼ -23.4% |
| 2014 | -0.27x | ILA-115.95 Million | ILA428.44 Million | ▲ +1.8% |
| 2013 | -0.28x | ILA-148.98 Million | ILA540.45 Million | ▼ -20.2% |
| 2012 | -0.23x | ILA-81.22 Million | ILA354.19 Million | ▲ +68.2% |
| 2011 | -0.72x | ILA-102.45 Million | ILA142.01 Million | ▲ +10.9% |
| 2010 | -0.81x | ILA-111.93 Million | ILA138.20 Million | ▼ -43.0% |
| 2009 | -0.57x | ILA-86.86 Million | ILA153.41 Million | ▼ -63.6% |
| 2008 | -0.35x | ILA-52.41 Million | ILA151.47 Million | ▲ +18.4% |
| 2007 | -0.42x | ILA-47.05 Million | ILA110.98 Million | ▲ +77.5% |
| 2006 | -1.88x | ILA-23.55 Million | ILA12.50 Million | — |